Peter Jeffrey Gilbar

19PUBLICATIONS
6CO-AUTHORS
AutoimmunityMolecular imaging (incl. electron microscopy and neutron diffraction)Cancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 28, 2022
Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab.

Aarya Murali, Philip Wong, Peter J Gilbar

|Jan 17, 2022
Immediate severe hypersensitivity reaction to etoposide phosphate: Case report and review of the literature.

Nicole R Pringle, Peter J Gilbar, Guranjan D Grewal

|Oct 14, 2021
Severe cisplatin-induced renal toxicity in a patient with xeroderma pigmentosum.

Peter J Gilbar, Khageshwor Pokharel

|Sep 17, 2021
Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer.

Hannah Van Belle, Sara A Hurvitz, Peter J Gilbar

|Jun 17, 2021
Preventing drug vial wastage and reducing expenditure associated with injectable cancer drugs: International oncology pharmacy survey.

Peter J Gilbar, Carole R Chambers, Felice Musicco

|May 15, 2021
Retrospective analysis of mortality within 30 days of systemic anticancer therapy and comparison with a previous audit at an Australian Regional Cancer Centre.

Bernadatte Zimbwa, Peter J Gilbar, Mark R Davis

Pageof 4